Circulating Truncated Alpha-1 Antitrypsin Glycoprotein in Patient Plasma Retains Anti-Inflammatory Capacity

The Journal of Immunology : Official Journal of the American Association of Immunologists
Emer P ReevesNoel G McElvaney

Abstract

Alpha-1 antitrypsin (AAT) is an acute phase protein that possesses immune-regulatory and anti-inflammatory functions independent of antiprotease activity. AAT deficiency (AATD) is associated with early-onset emphysema and chronic obstructive pulmonary disease. Of interest are the AATD nonsense mutations (termed null or Q0), the majority of which arise from premature termination codons in the mRNA coding region. We have recently demonstrated that plasma from an AATD patient homozygous for the Null Bolton allele (Q0bolton ) contains AAT protein of truncated size. Although the potential to alleviate the phenotypic consequences of AATD by increasing levels of truncated protein holds therapeutic promise, protein functionality is key. The goal of this study was to evaluate the structural features and anti-inflammatory capacity of Q0bolton-AAT. A low-abundance, truncated AAT protein was confirmed in plasma of a Q0bolton-AATD patient and was secreted by patient-derived induced pluripotent stem cell-hepatic cells. Functional assays confirmed the ability of purified Q0bolton-AAT protein to bind neutrophil elastase and to inhibit protease activity. Q0bolton-AAT bound IL-8 and leukotriene B4, comparable to healthy control M-AAT, and signif...Continue Reading

References

Nov 1, 1989·Analytical Biochemistry·S C Gill, P H von Hippel
Jan 1, 1982·Annual Review of Biochemistry·G Ashwell, J Harford
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R L HooverR A Lewis
Jun 14, 2000·American Journal of Respiratory and Critical Care Medicine·M M Van Den HeuvelW Van Dijk
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Aug 20, 2002·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·André M CantinRichard Leduc
Nov 22, 2002·American Journal of Respiratory Cell and Molecular Biology·André M CantinRichard Leduc
Oct 7, 2004·Clinics in Liver Disease·David H Perlmutter
Sep 28, 2006·The American Journal of Pathology·Irina PetracheRubin M Tuder
Oct 20, 2006·The European Respiratory Journal·M GrieseD Hartl
Mar 31, 2007·American Journal of Respiratory Cell and Molecular Biology·Andrew ChurgJoanne L Wright
Apr 24, 2007·Nature·Ellen M WelchH Lee Sweeney
Oct 30, 2007·Translational Research : the Journal of Laboratory and Clinical Medicine·Ilaria FerrarottiMaurizio Luisetti
Dec 14, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Farid ZerimechMalika Balduyck
Feb 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ming DuDavid M Bedwell
Mar 8, 2008·American Journal of Respiratory Cell and Molecular Biology·Andrew A WilsonDarrell N Kotton
Oct 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Eli C LewisCharles A Dinarello
Oct 30, 2009·The Journal of Gene Medicine·Christian GrimsteinSihong Song
Jul 14, 2010·American Journal of Respiratory and Critical Care Medicine·Isabelle Sermet-GaudelusLangdon L Miller
Nov 10, 2010·The Journal of Clinical Investigation·David A BerginNoel G McElvaney
Dec 8, 2010·Proteomics. Clinical Applications·Rosa PeracaulaPauline M Rudd
Feb 25, 2011·Journal of Translational Medicine·Christian GrimsteinSihong Song
Oct 7, 2011·Wiley Interdisciplinary Reviews. RNA·Kim M Keeling, David M Bedwell
Mar 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Yuko TsutsuiPatrick L Wintrode
Oct 2, 2012·Bioorganic & Medicinal Chemistry Letters·Ariamala GopalsamyKer Yu
Dec 1, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Adriana OrdóñezDavid A Lomas
Dec 12, 2012·Annual Review of Medicine·Stuart W PeltzAllan Jacobson
Mar 30, 2013·Human Molecular Genetics·Jake N MillerDavid A Pearce
Dec 29, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mei LiAnders Arner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.